The stories started appearing in 2023 and haven't stopped since.
Women who had tried for years to conceive—through IVF, fertility treatments, and heartbreak—were suddenly pregnant after starting Ozempic or Wegovy. Some called them "Ozempic babies." Social media lit up with testimonials.
At the same time, women became pregnant unexpectedly, believing their birth control was reliable. Some discovered pregnancies after weeks on GLP-1s, raising concerns about fetal exposure.
What's actually happening? Let's separate science from speculation.
⚠️ Critical Safety Note
GLP-1s should be stopped at least 2 months before attempting pregnancy. Semaglutide stays in the body for weeks after the last dose. Animal studies showed potential fetal harm. Do not rely on this article for medical decisions—discuss with your provider.
Why Might Fertility Improve?
The fertility boost is likely real—but it's probably the weight loss, not the drug itself.
The Weight-Fertility Connection
Obesity significantly impairs fertility through multiple mechanisms:
- PCOS: Polycystic ovary syndrome affects up to 70% of women with obesity. Weight loss can restore ovulation in many cases.
- Insulin resistance: High insulin levels disrupt reproductive hormones. GLP-1s dramatically improve insulin sensitivity.
- Hormone imbalance: Fat tissue produces estrogen, throwing off the delicate hormonal balance needed for ovulation.
- Inflammation: Chronic inflammation from obesity impairs egg quality and implantation.
Studies consistently show that 5-10% weight loss can restore ovulation in women with PCOS. GLP-1s produce 15-20%+ weight loss in many patients—well above this threshold.
The GLP-1 Receptor Question
There's also speculation that GLP-1 receptors in reproductive tissues might directly improve fertility. GLP-1 receptors exist in the ovaries and uterus, but we don't yet know if activating them meaningfully affects conception.
Current consensus: Weight loss and metabolic improvements are the most likely explanations. Direct reproductive effects are possible but unproven.
The Birth Control Problem
Here's where things get complicated for women who don't want to get pregnant.
GLP-1s May Reduce Oral Contraceptive Effectiveness
GLP-1 medications delay gastric emptying—food (and pills) stay in your stomach longer. This can affect how oral contraceptives are absorbed.
- Slower absorption: May reduce peak blood levels of contraceptive hormones
- Vomiting: GI side effects may expel pills before absorption
- Diarrhea: Can reduce absorption of any oral medication
The guidance: If you're on GLP-1s and rely on oral contraceptives, consider:
- Using a backup method (condoms)
- Switching to non-oral contraception (IUD, implant, injection)
- Being vigilant about timing pills with meals
Improved Fertility = More Pregnancy Risk
Even if your contraception works perfectly, if you were previously subfertile due to weight-related anovulation, you might now be ovulating regularly. Your baseline pregnancy risk increases.
If You Want to Get Pregnant
For women hoping to conceive:
- Use GLP-1s for weight optimization before attempting pregnancy. Get to a healthier weight, then stop the medication.
- Stop GLP-1s at least 2 months before trying to conceive. Semaglutide's half-life is about one week; tirzepatide's is about 5 days. It takes ~5 half-lives to clear your system.
- Work with your OB-GYN and weight management provider. They need to coordinate timing.
- Don't assume GLP-1s are a fertility treatment. They're not tested or approved for this purpose.
If You Get Pregnant on GLP-1s
Unplanned pregnancies on GLP-1s happen. If you discover you're pregnant:
- Stop the GLP-1 immediately.
- Contact your healthcare provider right away.
- Don't panic. Animal studies showed risks, but human data is limited. Many exposed pregnancies have resulted in healthy babies.
- Get appropriate prenatal monitoring. Your provider may recommend additional ultrasounds.
The Animal Data
Animal studies of semaglutide showed increased rates of birth defects and pregnancy loss at high doses. However, animal data doesn't always translate to humans, and the doses used were often much higher than human therapeutic doses. We simply don't have enough human pregnancy data yet.
During Pregnancy and Breastfeeding
GLP-1s are not recommended during pregnancy or breastfeeding.
- No controlled studies exist in pregnant women
- Animal studies suggest potential fetal risk
- Unknown whether GLP-1s pass into breast milk
- Weight loss during pregnancy is not recommended
Some women worry about weight regain after stopping for pregnancy. This is a legitimate concern—many patients regain weight when they stop GLP-1s. Discuss strategies with your provider, but don't continue GLP-1s during pregnancy to prevent regain.
Ongoing Research
Given the millions of women now taking GLP-1s, pregnancy data is accumulating. Studies are tracking:
- Outcomes of pregnancies with early GLP-1 exposure
- Whether GLP-1s directly affect fertility beyond weight loss
- Optimal washout periods before conception
- Long-term effects on children born after maternal GLP-1 use
Answers will come over the next several years as registries collect data.
The Bottom Line
The fertility boost is probably real—but it's the weight loss, not magic. GLP-1s help women lose weight, which can restore ovulation in those with PCOS and other weight-related fertility issues.
Key takeaways:
- If you want to get pregnant: Use GLP-1s for weight optimization, then stop 2+ months before trying to conceive
- If you don't want to get pregnant: Consider non-oral contraception and be aware that your fertility may have improved
- If you get pregnant on GLP-1s: Stop immediately and contact your provider—don't panic, but get proper monitoring
- GLP-1s are not fertility treatments: Don't use them for this purpose
Learn More About GLP-1s
Explore our resources on safety, efficacy, and choosing the right option.
Read More Articles →